Consolidated Data.
Identified Risk.
Informed Action.
Remarque Systems brings process optimization, increased visibility, rapid communications, and improved quality to your clinical trial data and operations.
Consolidate
Seamlessly import data from all disconnected repositories into one single platform. Immediately gain better visibility and oversight so you can take more informed actions.
Quickly identify known and unknown risks with trial-specific triggers — data outliers, adverse events, enrollment issues — in real-time. Improve data quality by reducing risky manual processes. Better manage risks with greater oversight, collaboration, and visibility.
Get real-time oversight and end-to-end visibility over all your clinical trial data. Streamline your operations with clear, conclusive analytics and reports based on AI-powered data-driven insights.
The Result
All clinical trial data flows through one powerful platform — empowering increased visibility, better insights, and more informed actions.
Organizations around the world use Remarque Systems to gain better clinical trial data insights.
Our Solution
Consolidating all clinical trial data under one powerful platform delivers higher quality data, deeper insights, and clear decision paths.
Our Platform
Vendor-neutral data aggregation. Enhance transparency, accuracy, and efficiency with end-to-end visibility and clear, conclusive analytics and reports in real-time.
Our Promise
Remarque Systems adapts to ever-changing clinical trial data and regulatory demands — helping you optimize your process along the way.
Case Study
“A nimble company with a focus on customer service, Remarque spent the time to brainstorm various configurations to find the optimal solution for their client, then was able to offer end-to-end deployment that noticeably abbreviated the implementation timeline. In short: They were able to launch the study in record time, while maintaining the safety of the trial team.”
Case Study
“We knew that implementing Remarque technology would improve our efficiency, but it was impossible to understand how dramatically our efficiency would increase until we actually implemented the technology and experienced the difference. We now do in 30 minutes what used to take a full 8-hour day.”
Article
Effective Trial Continuity In the Face of a Pandemic While social distancing and isolation are paramount, clinical trials must adapt to remain viable. However, many clinical trial sponsors still have questions about how to effectively gather collective insights and apply them to improve their clinical trials. The result is a call for risk-based quality management…